Literature DB >> 27708271

Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity.

Yasser Vega1, Sergio Arias1, Irene Paradisi1.   

Abstract

Martin-Bell syndrome is mainly caused by the expansion of CGG trinucleotide repeats (>200 CGG) in the first exon of the FMR1 gene, leading to hypermethylation of the promoter region and silencing of the FMR1 protein expression. These changes are responsible for a phenotype with varying degrees of mental retardation, a long face with large and protruding ears, macroorchidism and autistic behavior. There may also be, however, patients who exhibit typical features of the syndrome without any expansion in the FMR1 gene; thus, other mechanisms affecting the expression of the FMR1 gene were assessed in 25 out of 29 ascertained patients with the typical phenotype without full mutation. Promoter methylation status of FMR1, mutations in its sequence and copy number variations (CNVs) in genes associated with intellectual disability were investigated. In 25 independent male patients without expansion, the promoter region was unmethylated; one patient with a full mutation showed methylation mosaicism; and a female patient had 81.2% of CpG sites methylated and 18.8% hemimethylated. One heterozygous duplication in exon 6 of the PDCD6 gene (programmed cell death 6) and a heterozygous deletion in exon 5 of the CHL1 gene (cell adhesion molecule L1), respectively, were found in two independent patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27708271     DOI: 10.1038/jhg.2016.114

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  31 in total

1.  Screening for FMR1 mutations among the mentally retarded: prevalence of the fragile X syndrome in Spain.

Authors:  J M Millán; F Martínez; A Cadroy; J Gandía; M Casquero; M Beneyto; L Badía; F Prieto
Journal:  Clin Genet       Date:  1999-07       Impact factor: 4.438

2.  Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.

Authors:  B B de Vries; A M van den Ouweland; S Mohkamsing; H J Duivenvoorden; E Mol; K Gelsema; M van Rijn; D J Halley; L A Sandkuijl; B A Oostra; A Tibben; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  A distinct DNA-methylation boundary in the 5'- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome.

Authors:  Anja Naumann; Norbert Hochstein; Stefanie Weber; Ellen Fanning; Walter Doerfler
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

4.  Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1.

Authors:  R Stöger; T M Kajimura; W T Brown; C D Laird
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

5.  Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA).

Authors:  D A Koolen; W M Nillesen; M H A Versteeg; G F M Merkx; N V A M Knoers; M Kets; S Vermeer; C M A van Ravenswaaij; C G de Kovel; H G Brunner; D Smeets; B B A de Vries; E A Sistermans
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

6.  CALL gene is haploinsufficient in a 3p- syndrome patient.

Authors:  D Angeloni; N M Lindor; S Pack; F Latif; M H Wei; M I Lerman
Journal:  Am J Med Genet       Date:  1999-10-29

7.  Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo.

Authors:  Karen T Smith; Bradford Coffee; Daniel Reines
Journal:  Hum Mol Genet       Date:  2004-06-02       Impact factor: 6.150

8.  A 15-item checklist for screening mentally retarded males for the fragile X syndrome.

Authors:  M G Butler; T Mangrum; R Gupta; D N Singh
Journal:  Clin Genet       Date:  1991-05       Impact factor: 4.438

9.  CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior.

Authors:  Suzanna G M Frints; Peter Marynen; Dieter Hartmann; Jean-Pierre Fryns; Jean Steyaert; Melitta Schachner; Bettina Rolf; Katleen Craessaerts; An Snellinx; Karen Hollanders; Rudi D'Hooge; Peter P De Deyn; Guy Froyen
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

10.  Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.

Authors:  K A Lugenbeel; A M Peier; N L Carson; A E Chudley; D L Nelson
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  1 in total

1.  Close Homolog of L1 Regulates Dendritic Spine Density in the Mouse Cerebral Cortex Through Semaphorin 3B.

Authors:  Vishwa Mohan; Sarah D Wade; Chelsea S Sullivan; Michael R Kasten; Cassandra Sweetman; Rebeccah Stewart; Young Truong; Melitta Schachner; Paul B Manis; Patricia F Maness
Journal:  J Neurosci       Date:  2019-06-10       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.